This is the text extract for June Tender Notification; Contact: Notifications; Posted: 2012-06-29, browse documents here.

---

29 June 2012

TENDER RESULTS

The PHARMAC Board (or Chief Executive under Delegated Authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2011/12 Invitation to Tender, dated 1 November 2011. As discussed in our 2010 tender consultation document, we are notifying tender decisions as they are made in 2012. This change is to provide maximum notification of upcoming changes to the market, specifically to incumbent suppliers. Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website – www.pharmac.govt.nz/schedule.asp. Where a product does not have a current pharmacode, suppliers are required to ensure a pharmacode has been issued by the Pharmacy Guild of New Zealand before the 12th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct pharmacode.

A518504 - qA21977

Page 1 of 11

---

2011/12 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2015 Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

Current subsidy and (price) $5.70 $12.60 $8.68 $15.45 $264.17 $16.50 $32.80 $63.22 $17.60 $2.30 $6.85 $6.85 $6.85 New subsidy and price $5.70 $12.60 $8.68 $16.07 $198.13 $16.50 $24.52 $42.25 $17.60 $2.30 $6.85 $6.85 $6.85

The decisions were as follows:

Chemical name

Presentation; Pack size and type Tab long-acting 400 mg; 30 tablets, blister pack Tab 10 mg; 100 tablets, blister pack Tab 25 mg; 100 tablets, blister pack Inj 150 µg per ml, 1 ml; 5 ampoules Oral liq 100 mg per ml; 50 ml OP glass bottle Tab 5 mg; 100 tablets, glass bottle tab long-acting 75 mg; 500 tablets, plastic bottle tab long-acting 100 mg; 500 tablets, plastic bottle Tab 10 μg; 100 tablets, plastic bottle Lipocream 0.1%; 30 g OP tube Lipocream 0.1%; 100 g OP tube Milky emul 0.1%; 100 ml OP plastic bottle Oint 0.1%; 100 g OP aluminium tube

Sole supply brand (Supplier) Bezalip Retard (Actavis) Apo-Clomipramine (Apotex) Apo-Clomipramine (Apotex) Catapres (Boehringer) Neoral (Novartis) PSM (API) Diclax SR (Douglas) Diclax SR (Douglas) NZ Med & Sci (NZ Med & Sci) Locoid Lipocream (CSL) Locoid Lipocream (CSL) Locoid Crelo (CSL) Locoid (CSL)

Date of subsidy change

Sole Subsidised Supply date

Bezafibrate Clomipramine hydrochloride Clomipramine hydrochloride Clonidine hydrochloride Cyclosporin Dexamphetamine sulphate Diclofenac sodium Diclofenac sodium Ethinyloestradiol Hydrocortisone butyrate Hydrocortisone butyrate Hydrocortisone butyrate Hydrocortisone butyrate

1 August 2012 1 November 2012 1 November 2012 1 September 2012 1 August 2012 1 January 2013 1 October 2012 1 October 2012 1 August 2012 1 January 2013 1 January 2013 1 January 2013 1 January 2013

1 November 2012 1 February 2013 1 February 2013 1 December 2012 1 November 2012 1 April 2013 1 January 2013 1 January 2013 1 November 2012 1 April 2013 1 April 2013 1 April 2013 1 April 2013

A518504 - qA21977

Page 2 of 11

---

Chemical name Hydrocortisone butyrate Isoniazid Methylprednisolone Methylprednisolone Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate Methylprednisolone sodium succinate Morphine hydrochloride Morphine hydrochloride Morphine hydrochloride Morphine hydrochloride Oil in water emulsion

Presentation; Pack size and type Scalp lotn 0.1%; 100 ml OP plastic bottle Tab 100 mg; 100 tablets, plastic bottle Tab 100 mg; 20 tablets, glass bottle Tab 4 mg; 100 tablets, glass bottle/ blister pack Inj 40 mg per ml, 1 ml; 1 vial Inj 40 mg per ml with lignocaine 1 ml; 1 vial Inj 500 mg; 1 vial inj 1 g; 1 vial Oral liq 1 mg per ml; 200 ml, plastic bottle Oral liq 2 mg per ml; 200 ml, plastic bottle Oral liq 5 mg per ml; 200 ml, plastic bottle Oral liq 10 mg per ml; 200 ml, plastic bottle Crm; 500 g pot Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml; 5 glass ampoules Tab 50 mg; 10 tablets, glass bottle

Current subsidy and (price) $3.65 $20.00 $166.52 $48.57 $6.03

New subsidy and price $3.65 $20.00 $166.52 $60.00 $6.70

Sole supply brand (Supplier) Locoid (CSL) PSM (API) Medrol (Pfizer) Medrol (Pfizer) Depo-Medrol (Pfizer) Depo-Medrol with Lidocaine (Pfizer) Solu-Medrol (Pfizer) Solu-Medrol (Pfizer) RA-Morph (Pfizer) RA-Morph (Pfizer) RA-Morph (Pfizer) RA-Morph (Pfizer) healthE Fatty Cream (Jaychem) Syntometrine (Novartis) PSM (API)

Date of subsidy change

Sole Subsidised Supply date

1 January 2013 1 January 2013 1 August 2012 1 August 2012 1 August 2012

1 April 2013 1 April 2013 1 November 2012 1 November 2012 1 November 2012

$6.03

$7.50

1 August 2012

1 November 2012

$20.80 $42.57 $8.84 $11.62 $14.65 $21.55 $2.80

$18.00 $37.50 $8.84 $11.62 $14.65 $21.55 $2.63

1 August 2012 1 August 2012 1 August 2012 1 August 2012 1 August 2012 1 August 2012 1 October 2012

1 January 2013 1 January 2013 1 November 2012 1 November 2012 1 November 2012 1 November 2012 1 January 2013

Oxytocin Pethidine hydrochloride

$10.12

$11.13

1 August 2012

1 November 2012

$3.20

$3.95

1 January 2013

1 April 2013

A518504 - qA21977

Page 3 of 11

---

Chemical name Pethidine hydrochloride Phenobarbitone Phenobarbitone Potassium chloride Ritonavir

Presentation; Pack size and type Tab 100 mg; 10 tablets, glass bottle Tab 15 mg; 500 tablets, blister pack Tab 30 mg; 500 tablets, blister pack Tab long-acting 600 mg; 200 tablets, plastic bottle Tab 100 mg; 30 tablets, plastic bottle

Current subsidy and (price) $4.20 $25.00 $26.00 $7.00 $43.31

New subsidy and price $5.80 $28.00 $29.00 $7.42 $43.31

Sole supply brand (Supplier) PSM (API) PSM (API) PSM (API) Span-K (Aspen) Norvir (Abbott)

Date of subsidy change

Sole Subsidised Supply date

1 January 2013 1 January 2013 1 January 2013 1 August 2012 1 August 2012

1 April 2013 1 April 2013 1 April 2013 1 November 2012 1 November 2012

2.

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows: Chemical Name Presentation; Pack size and type Tab 200 mg; 90 tablets, blister pack Tab EC 25 mg; 100 tablets, plastic bottle Tab EC 50 mg; 500 tablets, plastic bottle Eye drops 0.1%; 5 ml OP bottle dropper Tab 5 mg; 90 tablets, plastic bottle Tab 10 mg; 90 tablets, plastic bottle Tab 20 mg; 90 tablets, plastic bottle Current New subsidy subsidy and and price (price) $9.75 $1.63 per 50 tablets $9.70 $4.00 per 100 tablets Sole supply brand (Supplier) Bezalip (Actavis) Apo-Diclo (Apotex) Apo-Diclo (Apotex) Flucon (Alcon) Arrow-Lisinopril (Arrow) Arrow-Lisinopril (Arrow) Arrow-Lisinopril (Arrow) Date of listing/subsidy change for tender winning brand 1 December 2012 1 January 2013 1 January 2013 1 October 2012 1 November 2012 1 November 2012 1 November 2012 Date of reference pricing of other listed brands 1 February 2013 N/A 1 March 2013 1 December 2012 N/A N/A N/A Sole Subsidised Brand (Supplier) Supply date (and affected by delisting of other reference pricing listed brands) and delisting 1 May 2013 1 June 2013 1 June 2013 1 March 2013 1 February 2013 1 February 2013 1 February 2013 Fibalip (Mylan) Diclofenac Sandoz (Sandoz) Diclofenac Sandoz (Sandoz) FML (Allergan) Arrow-Lisinopril (Arrow)* Arrow-Lisinopril (Arrow)* Arrow-Lisinopril (Arrow)*

Bezafibrate Diclofenac sodium Diclofenac sodium Fluorometholone Lisinopril Lisinopril Lisinopril

$2.13 per 50 $16.00 per 500 tablets tablets $4.05 $2.06 per 30 tablets $2.36 per 30 tablets $2.87 per 30 tablets $3.80 $3.58 per 90 tablets $4.08 per 90 tablets $4.88 per 90 tablets

A518504 - qA21977

Page 4 of 11

---

Chemical Name

Presentation; Pack size and type Tab 160 mg; 30 tablets, plastic bottle

Current New subsidy subsidy and and price (price) $57.92 $6.06 $16.50 $8.70 $14.40 $28.80 $51.55 $7.50 $18.50 $4.95 $10.08 $19.87

Sole supply brand (Supplier) Apo-Megestrol (Apotex) Solu-Medrol (Pfizer) Solu-Medrol (Pfizer) Decozol (AFT) Oxycodone Orion (Max Health) Oxycodone Orion (Max Health)

Date of listing/subsidy change for tender winning brand 1 November 2012 1 August 2012 1 August 2012 1 December 2012 1 October 2012 1 October 2012

Date of reference pricing of other listed brands 1 January 2013 N/A N/A 1 February 2013 1 December 2012 1 December 2012

Sole Subsidised Brand (Supplier) Supply date (and affected by delisting of other reference pricing listed brands) and delisting 1 April 2013 1 January 2013 1 January 2013 1 May 2013 1 March 2013 1 March 2013 Megace (BMS) Solu-Medrol (Pfizer)** Solu-Medrol (Pfizer)** Daktarin (Janssen-Cilag) OxyNorm (Mundipharma) OxyNorm (Mundipharma)

Megestrol acetate

Methylprednisolone Inj 40 mg per ml, 1 ml; 1 sodium succinate vial Methylprednisolone Inj 62.5 mg per ml, 2 ml; sodium succinate 1 vial Miconazole Oxycodone hydrochloride Oxycodone hydrochloride Oral gel 20 mg per g; 40 g OP tube Inj 10 mg per ml, 1 ml; 5 glass ampoules Inj 10 mg per ml, 2 ml; 5 glass ampoules

*Arrow’s brand of lisinopril tablets (30 tablet pack size) will be delisted from Section B of the Pharmaceutical Schedule from 1 February 2013. **Pfizer’s brand of methylprednisolone sodium succinate inj 40 mg per ml, 1 ml and inj 62.5 mg per ml, 2 ml (25 pack size) will be delisted from Section B of the Pharmaceutical Schedule on 1 January 2013.

A518504 - qA21977

Page 5 of 11

---

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

3. Tenders awarded to pharmaceuticals where no brand is listed.

Presentation; Pack size and type Inj 0.05 mg per ml, 1 ml; 1 glass ampoule Tab 10 mg; 100 tablets, blister pack Tab 25 mg; 100 tablets, blister pack tab long-acting 100 mg; 500 tablets, plastic bottle Tab EC 25 mg; 100 tablets, plastic bottle Tab EC 50 mg; 500 tablets, plastic bottle Oral gel 20 mg per g; 40 g tube Hospital Supply Brand (Supplier) Lioresal Intrathecal (Novartis) Apo-Clomipramine (Apotex) Apo-Clomipramine (Apotex) Diclax SR (Douglas) Apo-Diclo (Apotex) Apo-Diclo (Apotex) Decozol (AFT) DV Limit 1% 1% 1% 1% 1% 1% 1%

The decisions were as follows:

Chemical Name Baclofen Clomipramine hydrochloride Clomipramine hydrochloride Diclofenac sodium Diclofenac sodium Diclofenac sodium Miconazole

Pack price $11.55 $12.60 $8.68 $42.25 $4.00 per 100 tablets $16.00 per 500 tablets $4.95

Listing date 1 August 2012 1 November 2012 1 November 2012 1 October 2012 1 January 2013 1 January 2013 1 December 2012

Hospital Supply Status date 1 October 2012 1 January 2013 1 January 2013 1 December 2012 1 March 2013 1 March 2013 1 February 2013

4.

Tenders awarded to listed pharmaceuticals where only the current brand is listed.

Chemical Name Alprostadil Amphotericin B liposomal Baclofen Bezafibrate Presentation; Pack size and type Inj 0.5 mg per ml, 1 ml; 5 ampoules Inj 50 mg; 10 vials Inj 2 mg per ml, 5 ml; 1 glass ampoule Tab long-acting 400 mg; 30 tablets, blister pack Current pack price $1,417.50 $3,450.00 $190.08 $5.70 New pack price $1,417.50 $3,450.00 $209.29 $5.70 Hospital Supply Brand (Supplier) Prostin VR (Pfizer) AmBisome (Gilead Sciences) Lioresal Intrathecal (Novartis) Bezalip Retard (Actavis) DV Limit 1% 1% 1% 1% Date of price change 1 August 2012 1 August 2012 1 August 2012 1 August 2012 Hospital Supply Status date 1 October 2012 1 October 2012 1 October 2012 1 October 2012

The decisions were as follows:

A518504 - qA21977

Page 6 of 11

---

Chemical Name Bupivacaine hydrochloride Bupivacaine hydrochloride Bupivacaine hydrochloride Caspofungin Caspofungin Chlorhexidine Clonidine hydrochloride Cyclosporin Cyclosporin Dexamphetamine sulphate Diclofenac sodium Glyceryl trinitrate Glyceryl trinitrate Hydrocortisone butyrate Hydrocortisone butyrate Hydrocortisone butyrate Hydrocortisone butyrate

Presentation; Pack size and type Inj 0.25%, 20 ml; 5 polyamps Inj 0.5%, 10 ml theatre pack; 5 polyamps Inj 0.5%, 20 ml theatre pack; 5 polyamps Inj 50 mg; 1 glass vial Inj 70 mg; 1 glass vial Crm 1% obstetric; 50 g, tube Inj 150 µg per ml, 1 ml; 5 ampoules Inf 50 mg per ml, 5 ml; 10 ampoules Oral liq 100 mg per ml; 50 ml glass bottle Tab 5 mg; 100 tablets, glass bottle Tab long-acting 75 mg; 500 tablets, plastic bottle Inj 1 mg per ml, 5 ml; 10 glass ampoules Inj 1 mg per ml, 50 ml; 10 glass vials Lipocream 0.1%; 30 g tube Lipocream 0.1%; 100 g tube Milky emul 0.1%; 100 ml plastic bottle Oint 0.1%; 100 g aluminium tube

Current pack price $35.00 $28.00 $25.00 $667.50 $862.50 $1.36 $15.45 $276.30 $264.17 $16.50 $32.80 $22.70 $86.60 $2.30 $6.85 $6.85 $6.85

New pack price $35.00 $28.00 $28.00 $667.50 $862.50 $1.24 $16.07 $276.30 $198.13 $16.50 $24.52 $22.70 $86.60 $2.30 $6.85 $6.85 $6.85

Hospital Supply Brand (Supplier) Marcain (AstraZeneca) Marcain (AstraZeneca) Marcain (AstraZeneca) Cancidas (MSD) Cancidas (MSD) healthE (Jaychem) Catapres (Boehringer) Sandimmun (Novartis) Neoral (Novartis) PSM (API) Diclax SR (Douglas) Nitronal (Douglas) Nitronal (Douglas) Locoid Lipocream (CSL) Locoid Lipocream (CSL) Locoid Crelo (CSL) Locoid (CSL)

DV Limit 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1%

Date of price change 1 August 2012 1 August 2012 1 August 2012 1 August 2012 1 August 2012 1 August 2012 1 September 2012 1 August 2012 1 August 2012 1 January 2013 1 October 2012 1 October 2012 1 October 2012 1 January 2013 1 January 2013 1 January 2013 1 January 2013

Hospital Supply Status date 1 October 2012 1 October 2012 1 October 2012 1 October 2012 1 October 2012 1 October 2012 1 November 2012 1 October 2012 1 October 2012 1 March 2013 1 December 2012 1 December 2012 1 December 2012 1 March 2013 1 March 2013 1 March 2013 1 March 2013

A518504 - qA21977

Page 7 of 11

---

Chemical Name Hydrocortisone butyrate Isoniazid Methylprednisolone Methylprednisolone Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate Methylprednisolone sodium succinate Morphine hydrochloride Morphine hydrochloride Morphine hydrochloride Morphine hydrochloride Oil in water emulsion

Presentation; Pack size and type Scalp lotn 0.1%; 100 ml plastic bottle Tab 100 mg; 100 tablets, plastic bottle Tab 100 mg; 20 tablets, glass bottle Tab 4 mg; 100 tablets, glass bottle/ blister pack Inj 40 mg per ml, 1 ml; 1 vial Inj 40 mg per ml with lignocaine 1 ml; 1 vial Inj 500 mg; 1 vial inj 1 g; 1 vial Oral liq 1 mg per ml; 200 ml, plastic bottle Oral liq 2 mg per ml; 200 ml, plastic bottle Oral liq 5 mg per ml; 200 ml, plastic bottle Oral liq 10 mg per ml; 200 ml, plastic bottle Crm; 500 g pot Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml; 5 glass ampoules Tab 50 mg; 10 tablets, glass bottle

Current pack price $3.65 $20.00 $166.52 $48.57 $6.03

New pack price $3.65 $20.00 $166.52 $60.00 $6.70

Hospital Supply Brand (Supplier) Locoid (CSL) PSM (API) Medrol (Pfizer) Medrol (Pfizer) Depo-Medrol (Pfizer) Depo-Medrol with Lidocaine (Pfizer) Solu-Medrol (Pfizer) Solu-Medrol (Pfizer) RA-Morph (Pfizer) RA-Morph (Pfizer) RA-Morph (Pfizer) RA-Morph (Pfizer) healthE Fatty Cream (Jaychem) Syntometrine (Novartis) PSM (API)

DV Limit 1% 1% 1% 1% 1%

Date of price change 1 January 2013 1 January 2013 1 August 2012 1 August 2012 1 August 2012

Hospital Supply Status date 1 March 2013 1 March 2013 1 October 2012 1 October 2012 1 October 2012

$6.03

$7.50

1%

1 August 2012

1 October 2012

$20.80 $42.57 $8.84 $11.62 $14.65 $21.55

$18.00 $37.50 $8.84 $11.62 $14.65 $21.55

1% 1% 1% 1% 1% 1%

1 August 2012 1 August 2012 1 August 2012 1 August 2012 1 August 2012 1 August 2012

1 October 2012 1 October 2012 1 October 2012 1 October 2012 1 October 2012 1 October 2012

$2.80

$2.63

1%

1 October 2012

1 December 2012

Oxytocin Pethidine hydrochloride

$10.12

$11.13

1%

1 August 2012

1 October 2012

$3.20

$3.95

1%

1 January 2013

1 March 2013

A518504 - qA21977

Page 8 of 11

---

Chemical Name Pethidine hydrochloride Phenobarbitone Phenobarbitone Potassium chloride Ritonavir Sodium hyaluronate

Presentation; Pack size and type Tab 100 mg; 10 tablets, glass bottle Tab 15 mg; 500 tablets, blister pack Tab 30 mg; 500 tablets, blister pack Tab long-acting 600 mg; 200 tablets, plastic bottle Tab 100 mg; 30 tablets, plastic bottle Ophthalmic inj 14 mg per ml; 1 syringe

Current pack price $4.20 $25.00 $26.00 $7.00 $43.31 $50.00

New pack price $5.80 $28.00 $29.00 $7.42 $43.31 $50.00

Hospital Supply Brand (Supplier) PSM (API) PSM (API) PSM (API) Span-K (Aspen) Norvir (Abbott) Healon GV (AMO)

DV Limit 1% 1% 1% 1% 1% 1%

Date of price change 1 January 2013 1 January 2013 1 January 2013 1 August 2012 1 August 2012 1 August 2012

Hospital Supply Status date 1 March 2013 1 March 2013 1 March 2013 1 October 2012 1 October 2012 1 October 2012

5.

Tenders awarded to listed pharmaceuticals where at least one other brand is listed.

Presentation; Pack size and type Inj 250 mg; 5 vials Tab 200 mg; 90 tablets, blister pack Inj 10 mg per ml, 15 ml; 1 glass vial Inj 10 mg per ml, 45 ml; 1 glass vial Inj 1 g; 1 glass vial Inj 2 g; 1 glass vial Eye drops 0.1%; 5 ml OP bottle dropper Current pack price $25.50 $9.75 $22.50 $50.00 $19.55 $39.10 $4.05 New pack Price $14.09 $9.70 $19.50 $48.50 $8.80 $17.60 $3.80 Hospital Supply Brand (Supplier) ZOVIRAX IV (GSK) Bezalip (Actavis) Carbaccord (Arrow) Carbaccord (Arrow) DBL Cefepime (Hospira) DBL Cefepime (Hospira) Flucon (Alcon) DV Limit 1% 1% 1% 1% 1% 1% 1% Date of listing/price change for tender winning brand 1 January 2013 1 December 2012 1 November 2012 1 November 2012 1 August 2012 1 August 2012 1 October 2012 Hospital Supply Status date (and delisting of other listed brands) 1 March 2013 1 February 2013 1 January 2013 1 January 2013 1 October 2012 1 October 2012 1 December 2012 Brand (Supplier) to be delisted Pfizer (Pfizer) Fibalip (Mylan) Carboplatin Ebewe (Sandoz) Carboplatin Ebewe (Sandoz) Maxipime (BMS) Maxipime (BMS) FML (Allergan)

The decisions were as follows:

Chemical Name

Aciclovir Bezafibrate Carboplatin* Carboplatin* Cefepime hydrochloride Cefepime hydrochloride Fluorometholone

A518504 - qA21977

Page 9 of 11

---

Chemical Name

Presentation; Pack size and type Gel 2%; 20 ml plastic tube Tab 5 mg; 90 tablets, plastic bottle Tab 10 mg; 90 tablets, plastic bottle Tab 20 mg; 90 tablets, plastic bottle Tab 160 mg; 30 tablets, plastic bottle

Current pack price $6.00 $2.06 per 30 tablets $2.36 per 30 tablets $2.87 per 30 tablets $57.92 $6.06 $16.50 $14.40 $28.80 $35.00

New pack Price $3.40 $3.58 per 90 tablets $4.08 per 90 tablets $4.88 per 90 tablets $51.55 $7.50 $18.50 $10.08 $19.87 $30.00

Hospital Supply Brand (Supplier) Orion (Orion) Arrow-Lisinopril (Arrow) Arrow-Lisinopril (Arrow) Arrow-Lisinopril (Arrow) Apo-Megestrol (Apotex) Solu-Medrol (Pfizer) Solu-Medrol (Pfizer) Oxycodone Orion (Max Health) Oxycodone Orion (Max Health) Provisc (Alcon)

DV Limit 1% 1% 1% 1% 1% 1% 1% 1% 1% 1%

Date of listing/price change for tender winning brand 1 August 2012 1 November 2012 1 November 2012 1 November 2012 1 November 2012 1 August 2012 1 August 2012 1 October 2012 1 October 2012 1 August 2012

Hospital Supply Status date (and delisting of other listed brands) 1 October 2012 1 January 2013 1 January 2013 1 January 2013 1 January 2013 1 October 2012 1 October 2012 1 December 2012 1 December 2012 1 October 2012

Brand (Supplier) to be delisted Xylocaine Jelly (AstraZeneca) Arrow-Lisinopril (Arrow)** Arrow-Lisinopril (Arrow)** Arrow-Lisinopril (Arrow)** Megace (BMS) Solu-Medrol (Pfizer)^ Solu-Medrol (Pfizer)^ OxyNorm (Mundipharma) OxyNorm (Mundipharma) Healon (AMO)

Lignocaine Lisinopril Lisinopril Lisinopril Megestrol acetate

Methylprednisolone Inj 40 mg per ml, 1 ml; 1 vial sodium succinate Methylprednisolone sodium succinate Oxycodone hydrochloride Oxycodone hydrochloride Sodium hyaluronate Inj 62.5 mg per ml, 2 ml; 1 vial Inj 10 mg per ml, 1 ml; 5 glass ampoules Inj 10 mg per ml, 2 ml; 5 glass ampoules Ophthalmic soln 10 mg per ml, 1 ml; 1 syringe

* The price and subsidy of carboplatin (PCT only) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 November 2012. The subsidy for carboplatin inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $0.15 per 1 mg to $0.13 per 1 mg from 1 January 2013. **Arrow’s brand of lisinopril tablets (30 tablet pack size) will be delisted in Part II of Section H of the Pharmaceutical Schedule from 1 January 2013. ^Pfizer’s brand of methylprednisolone sodium succinate inj 40 mg per ml, 1 ml (25 pack size) and inj 62.5 mg per ml, 2 ml (25 pack size) will be delisted in Part II of Section H of the Pharmaceutical Schedule on 1 October 2012.

A518504 - qA21977

Page 10 of 11

---

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

The PHARMAC Board (or Chief Executive under Delegated Authority) resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2010/11 Invitation to Tender, dated 2 November 2010:

Chemical Name Line Item

Hypromellose

Eye drops 0.3% with or without dextran

The PHARMAC Board (or Chief Executive under Delegated Authority) resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2011/12 Invitation to Tender, dated 1 November 2011:

Chemical Name Line Item Chemical Name Line Item

Codeine phosphate Codeine phosphate Codeine phosphate Emtricitabine Fluconazole Goserelin acetate

Tab 15 mg Tab 30 mg Tab 60 mg Cap 200 mg Inj 2 mg per ml, 50 ml Inj 10.8 mg

Latanoprost with timolol Pregnancy tests - HCG Urine Pholcodine Sotalol Sotalol Travoprost with timolol

Eye drops 50 mcg per ml with timolol 0.5% Urine diagnostic test Oral liquid 1 mg per ml Tab 80 mg Tab 160 mg Eye drops 0.004% with timolol 0.5%

For products included in the 2010/11 Invitation to Tender and 2011/12 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or Chief Executive) approval. We will keep you informed of any updates regarding such tender products as decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A518504 - qA21977

Page 11 of 11